Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Denali BioTechnologies is a health-focused biotechnology company specializing in the research and development of functional food ingredients and dietary supplements derived from wild Alaskan flora. The company focuses on the unique chemical profiles of plants grown in extreme northern environments, which often produce higher concentrations of bioactive compounds like anthocyanins and antioxidants. Their flagship product, AuroraBlue, is a proprietary complex of wild Alaskan blueberries clinically studied for its benefits in cognitive health and anti-aging. Denali BioTechnologies provides high-quality, science-backed natural extracts to the global nutraceutical, cosmetic, and functional food industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Denali BioTechnologies.